Effect on recovery of patients with liver disease undergoing upper gastrointestinal endoscopy under propofol sedatio
Not Applicable
- Conditions
- Health Condition 1: K00-K95- Diseases of the digestive system
- Registration Number
- CTRI/2019/08/020586
- Lead Sponsor
- Gaurav Sndwani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Child class A,B and C
Patients undergoing upper gastrointestinal endoscopy under propofol sedation
Exclusion Criteria
Pregnant patients
Patients with a history of (H/O) Drug abuse
Patients refusing consent
History of Acute kidney injury
Obese patients BMI > 30
H/o allergy to propofol
Post liver transplant patients
Tense ascites patients
Patients undergoing upper gastrointestinal endoscopy under local anaesthesia
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the time of recovery in between the child class A,B and C cirrhotic patients who will be undergoing upper gastrointestinal endoscopy under propofol sedation. <br/ ><br>Timepoint: Until patient is discharged or shifted back to recovery
- Secondary Outcome Measures
Name Time Method To compare the total dose of propofol required for the procedure in between the child class A,B and C cirrhotic patients <br/ ><br>To compare the haemodynamic changes in between the child class A,B and C cirrhotic patients <br/ ><br>To compare the incidence and duration of post procedure hepatic encephalopathy among cirrhotic patients <br/ ><br>Timepoint: Until patient is discharged or shifted back to recovery